The Economic Times

USFDA classifies Aurobindo Pharma's US facility as 'official action indicated'

The facility belongs to Lannett Company LLC, a wholly owned step-down subsidiary of Aurobindo Pharma. The US Food and Drug Administration (USFDA) conducted the inspection at the Seymour facility from August 17-21, 2026, Aurobindo Pharma said in a regulatory filing.